We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amgen Files ITC Complaint Over Roche Anemia Drug

Law360 (April 12, 2006, 12:00 AM EDT) -- In a move to block pharmaceutical company Roche Holding AG’s experimental anemia drug from entering the United States, biotechnology company Amgen Inc. filed a complaint Tuesday with the U.S. International Trade...
To view the full article, register now.